Ami Fadia
Stock Analyst at Needham
(4.57)
# 208
Out of 5,090 analysts
406
Total ratings
53.41%
Success rate
26.06%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $250 → $304 | $247.99 | +22.59% | 15 | Dec 5, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $42 | $39.83 | +5.45% | 39 | Nov 24, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $16 | $7.92 | +102.02% | 22 | Nov 24, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $66 → $72 | $79.64 | -9.59% | 27 | Nov 6, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $28 → $29 | $27.44 | +5.69% | 12 | Nov 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $154 | $149.22 | +3.20% | 17 | Nov 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $184 | $155.51 | +18.32% | 16 | Oct 29, 2025 | |
| ALKS Alkermes | Maintains: Buy | $43 → $44 | $29.52 | +49.05% | 4 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Buy | $6 → $8 | $2.22 | +260.36% | 10 | Oct 28, 2025 | |
| AVDL Avadel Pharmaceuticals | Downgrades: Hold | n/a | $21.34 | - | 37 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $14.89 | +27.60% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.32 | +177.78% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $12.35 | +126.72% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.40 | +71.88% | 20 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $96 | $96.14 | -0.15% | 31 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $181.30 | - | 43 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $169.70 | +19.03% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $38.77 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $29.91 | +17.02% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.07 | +310.18% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $16.54 | +1,834.70% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.99 | +212.63% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.47 | +4,666.95% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $13.44 | +368.75% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $28.46 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.31 | +1,579.39% | 4 | Jan 3, 2018 |
Praxis Precision Medicines
Dec 5, 2025
Maintains: Buy
Price Target: $250 → $304
Current: $247.99
Upside: +22.59%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $42
Current: $39.83
Upside: +5.45%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $16
Current: $7.92
Upside: +102.02%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $66 → $72
Current: $79.64
Upside: -9.59%
ACADIA Pharmaceuticals
Nov 6, 2025
Maintains: Buy
Price Target: $28 → $29
Current: $27.44
Upside: +5.69%
Axsome Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $154
Current: $149.22
Upside: +3.20%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $170 → $184
Current: $155.51
Upside: +18.32%
Alkermes
Oct 29, 2025
Maintains: Buy
Price Target: $43 → $44
Current: $29.52
Upside: +49.05%
Neumora Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.22
Upside: +260.36%
Avadel Pharmaceuticals
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $21.34
Upside: -
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $14.89
Upside: +27.60%
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $4.32
Upside: +177.78%
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $12.35
Upside: +126.72%
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.40
Upside: +71.88%
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $96.14
Upside: -0.15%
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $181.30
Upside: -
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $169.70
Upside: +19.03%
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $38.77
Upside: -
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $29.91
Upside: +17.02%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.07
Upside: +310.18%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $16.54
Upside: +1,834.70%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.99
Upside: +212.63%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.47
Upside: +4,666.95%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $13.44
Upside: +368.75%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $28.46
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.31
Upside: +1,579.39%